Article metrics

Download PDFPDF
ADAGIO: a phase IIb international study of the Wee1 inhibitor adavosertib in women with recurrent or persistent uterine serous carcinoma

 

Online download statistics by month:

Online download statistics by month: October 2021 to June 2022

AbstractFullPdf
Oct 202135521
Nov 20218521714
Dec 2021432910
Jan 20229922519
Feb 202215251413
Mar 2022249135
Apr 202218756
May 2022246811
Jun 202230585
Total514310184